Labcorp Holdings Inc. (LH): Total Liabilities
$9.76B
As of 2025-12-31
$9.91B
As of 2026-06-30
-1.0%
3-year compound annual growth
-1.7%
5-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $9.76B | -5.4% | 2026-02-24, Balance as of period end |
| 2024-12-31 | $10.31B | +16.7% | 2026-02-24, Balance as of period end |
| 2023-12-31 | $8.83B | -12.0% | 2025-02-25, Balance as of period end |
| 2022-12-31 | $10.04B | -0.5% | 2024-02-26, Balance as of period end |
| 2021-12-31 | $10.09B | -4.9% | 2023-02-28, Balance as of period end |
| 2020-12-31 | $10.61B | +1.5% | 2022-02-25, Balance as of period end |
| 2019-12-31 | $10.46B | +13.8% | 2021-02-25, Balance as of period end |
| 2018-12-31 | $9.19B | -6.6% | 2020-02-28, Balance as of period end |
| 2017-12-31 | $9.85B | n/c | 2019-02-28, Balance as of period end |
| 2016-12-31 | $8.73B | -4.6% | 2018-02-27, Balance as of period end |
| 2015-12-31 | $9.14B | n/c | 2017-02-27, Balance as of period end |
| 2014-12-31 | $4.46B | +0.2% | 2016-03-01, Balance as of period end |
| 2013-12-31 | $4.46B | +9.8% | 2015-02-26, Balance as of period end |
| 2012-12-31 | $4.06B | +13.1% | 2014-02-25, Balance as of period end |
| 2011-12-31 | $3.59B | -3.0% | 2013-02-26, Balance as of period end |
| 2010-12-31 | $3.70B | +35.5% | 2012-02-24, Balance as of period end |
| 2009-12-31 | $2.73B | -4.5% | 2011-03-07, Balance as of period end |
| 2008-12-31 | $2.86B | n/a | 2010-02-24, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Labcorp Holdings Inc. (LH) | 2025-12-31 | $9.76B | -5.4% |
| Fortrea Holdings Inc. (FTRE) | 2025-12-31 | $2.15B | -2.9% |
| Natera, Inc. (NTRA) | 2025-12-31 | $685.93M | +47.4% |
| RadNet, Inc. (RDNT) | 2025-12-31 | $2.40B | +11.6% |
| Guardant Health, Inc. (GH) | 2025-12-31 | $2.11B | +30.0% |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | $548.36M | -11.7% |
| Veracyte, Inc. (VCYT) | 2025-12-31 | $96.44M | -22.3% |
| CareDx, Inc. (CDNA) | 2025-12-31 | $110.13M | -2.2% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $107.68M | +42.8% |
Compare LH, FTRE, NTRA, RDNT side by side · Screen every company in Services-Medical Laboratories ↗